CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Shanghai Fosun Pharmaceutical (Group) Company Limited Company Snapshot
Business Description:
Shanghai Fosun Pharmaceutical (Group) Company Limited operates in the Medicinals and botanicals sector. Shanghai Fosun Pharmaceutical (Group) Co., Ltd is a China-based company engaged in research, development, production, distribution and retailing of medical products. The Company's principal products are pharmaceuticals for malarias, such as Artesunate Tablets; pharmaceuticals for liver inflammations, such as Atomolan; pharmaceuticals for female diseases, such as Huahong Tablets, as well as pharmaceuticals for diabetes, such as insulin injection. The Company also provides pharmaceuticals for cardiovascular diseases, antineoplastic drugs, pharmaceuticals for sick disease, pediatrics drugs and gastrointestinal tract drugs, among others. The Company also operates regular chain drug stores. It distributes its products primarily in domestic and overseas markets. In our complete report available for purchase the company is compared to: Zhejiang Hisun Pharmaceutical, Ltd., Beijing Double-Crane Pharmaceutical Company Limited and Jiangsu Hengrui Medicine Co., Ltd..
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanghai Fosun Pharmaceutical (Group) Company Limited
  Stock Performance Chart for Shanghai Fosun Pharmaceutical (Group) Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (2/10/2012): 8.90
(Figures in Chinese Renmimbi)
1 Week 1.6%   13 Weeks 7.1%  
4 Weeks -12.0%   52 Weeks -28.4%  
 
Shanghai Fosun Pharmaceutical (Group) Company Limited Key Data:
  Ticker: 600196 Country: CHINA
  Exchanges: SHG Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 4,552,526,000
(Year Ending Jan 2011).		 Employees: 11,484
  Currency: Chinese Renmimbi Market Cap: 16,949,092,040
  Fiscal Yr Ends: December Shares Outstanding: 1,904,392,364
  Share Type: A Gu Closely Held Shares: 1,661,502,666
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.